TMCnet News

Research and Markets: Alopecia Therapeutics Pipeline Review 2015 - 11 Companies & 17 Drug Profiles
[March 04, 2015]

Research and Markets: Alopecia Therapeutics Pipeline Review 2015 - 11 Companies & 17 Drug Profiles


Research and Markets (http://www.researchandmarkets.com/research/sxs4f4/alopecia) has announced the addition of the "Alopecia - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Alopecia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alopecia and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to reate effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.



Companies Involved in Therapeutics Development

  • AndroScience Corporation
  • Bristol-Myers Squibb Company
  • C3 (News - Alert) Jian, Inc
  • Follicum AB
  • Kuhnil Pharmaceutical Co., Ltd.
  • Lee's Pharmaceutical Holdings Limited
  • Panacea Biotec Limited
  • ProCertus BioPharm Inc.
  • Taisho Pharmaceutical Co., Ltd.
  • Tigo GmbH
  • Vida Therapeutics Inc.

Drug Profiles


  • abatacept (recombinant)
  • ASCJ-9
  • calcitriol
  • DHL-HisZnNa
  • interferon beta-1b
  • KI-1104
  • KI-1105
  • Peptide for Alopecia
  • Peptide for Alopecia and Chemotherapy Effects
  • ProDermaCel
  • Recombinant Peptides for Alopecia
  • Recombinant Proteins to Antagonize IFN-Gamma Receptor for Alopecia Areata and Graft Arteriosclerosis
  • Small Molecule to Inhibit ALK5 for Alopecia and Fibrosis
  • Small Molecules to Activate P2Y5 Receptor for Alopecia
  • Small Molecules to Inhibit Plasminogen Activator Inhibitor-1 for Thromboembolic Disease, PCOS and Alopecia
  • V-2248
  • ZK-003

For more information visit http://www.researchandmarkets.com/research/sxs4f4/alopecia


[ Back To TMCnet.com's Homepage ]